Author

Dahlya Kamarudin

Van Andel Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Abigail E. EllisiD· 1 shared Alexander C. MonovichiD· 1 shared Benjamin K. JohnsoniD· 1 shared Brandon M. OswaldiD· 1 shared Christine N. IsaguirreiD· 1 shared Colton Dysart· 1 shared Connie M. KrawczykiD· 1 shared Connor G Burke· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Abigail E. EllisORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

EZH2-driven immune evasion at disease presentation defines atargetable high-risk subset of acute leukemia exemplified byt(16;21) FUS::ERG AML

Nathaniel J. Buteyn, Samantha J LaMantia, Connor G Burke, Vincent J Sartori, Yizhou Peter Huang, Colton Dysart, Eve Deering-Gardner, Zachary J. DeBruine, Dahlya Kamarudin, Darrell P. Chandler, Alexander C. Monovich, Monika W. Perez, Joanna S. Yi, Rhonda E. Ries, Todd A. Alonzo, , Timothy Junius Triche

This paper identifies an EZH2-driven immune evasion phenotype in FUS::ERG AML that is reversible with tazemetostat, offering a potential targeted therapy for high-risk acute leukemia.

Blood Neoplasia · Sep 1, 2026Peer-reviewedCancer Biology

Dietary Restriction Enhances CD8+ T Cell Ketolysis to Limit Exhaustion and Boost Anti-Tumor Immunity

Brandon M. Oswald, Lisa M. DeCamp, Joseph Longo, Michael S. Dahabieh, Nicholas Bunda, Benjamin K. Johnson, McLane J. Watson, Shixin Ma, Samuel E.J. Preston, Ryan D. Sheldon, Michael P. Vincent, Abigail E. Ellis, Molly T. Soper-Hopper, Christine N. Isaguirre, Dahlya Kamarudin, , Russell G. Jones

This study shows dietary restriction enhances CD8+ T cell ketolysis, improving mitochondrial function and anti-tumor immunity by reducing exhaustion.

Nature Metabolism · Dec 9, 2025Peer-reviewedImmunology